Case Details
- Citation: [2025] SGCA 3
- Title: CH Biovest Pte Ltd v Envy Asset Management Pte Ltd (in liquidation) and others
- Court: Court of Appeal of the Republic of Singapore
- Court File No: Civil Appeal No 23 of 2024
- Originating Application: Originating Application No 311 of 2023
- Date of Decision: 4 February 2025
- Hearing Date: 16 October 2024
- Judges: Sundaresh Menon CJ, Steven Chong JCA and Kannan Ramesh JAD
- Appellant: CH Biovest Pte Ltd
- Respondents: Envy Asset Management Pte Ltd (in liquidation); Bob Yap Cheng Ghee; Tay Puay Cheng; Toh Ai Ling
- Role of Respondents: Liquidators (second to fourth respondents) appointed for the Envy group companies
- Legal Area: Insolvency Law — Avoidance of transactions
- Core Statutory Provisions: s 73B of the Conveyancing and Law of Property Act (Cap 61, 1994 Rev Ed) (“CLPA”); s 224 of the Insolvency, Restructuring and Dissolution Act 2018 (Act 40 of 2018) (“IRDA”)
- Other Statutory References (as pleaded/considered): s 438 and s 439 of the IRDA (as referenced in the court’s discussion)
- Statutes Referenced: Conveyancing and Law of Property Act (Cap 61, 1994 Rev Ed) (“CLPA”); Insolvency, Restructuring and Dissolution Act 2018 (Act 40 of 2018) (“IRDA”); Uniform Fraudulent Transfer Act (mentioned in the metadata)
- Lower Court: General Division of the High Court
- High Court Citation: Envy Asset Management Pte Ltd (in liquidation) and others v CH Biovest Pte Ltd [2024] SGHC 46
- Judgment Length: 49 pages; 15,235 words
- Precedents Cited (as per metadata): [2008] SGHC 133; [2024] SGCA 57; [2024] SGHC 46; [2025] SGCA 3
Summary
In CH Biovest Pte Ltd v Envy Asset Management Pte Ltd (in liquidation) and others [2025] SGCA 3, the Court of Appeal upheld the liquidators’ clawback of “profits” paid to an investor who had profited from a Ponzi-like nickel trading scheme run by the Envy group. The investor, CH Biovest, argued that it was contractually entitled to the payments and that the statutory avoidance provisions were inapplicable because the money was held on trust for investors. It also contended that the liquidators had chosen the wrong statutory route and that, in any event, the statutory elements were not satisfied.
The Court of Appeal dismissed the appeal. It confirmed that the liquidators could invoke the relevant avoidance provisions—s 73B of the CLPA for payments made before 30 July 2020 and s 224 of the IRDA for later payments—to recover the “Overwithdrawn Sums”, being the excess paid to the investor beyond its principal. The court rejected the investor’s trust-based and contractual entitlement defences, and it found that the statutory requirements for avoidance were met, including the lack of adequate value/consideration for the clawed payments and the statutory conditions relating to the debtor’s inability to pay its debts.
What Were the Facts of This Case?
The dispute arose from the collapse of the Envy group’s purported business of purchasing and reselling nickel. Investors were invited to fund the purchase of London Metal Exchange (“LME”) Nickel Grade Metal at a discount, with the promise that EAM (Envy Asset Management Pte Ltd) would resell the nickel at a higher price and share the resulting profits with investors. The investment structure was implemented through Letters of Agreement (“LOAs”) under which investors paid an “Investment Amount” for a three-month period and were entitled to receive the Investment Amount plus “Appreciation”, defined as the fair market value increase of EAM’s liquid assets after deducting stipulated fees. Investors were also guaranteed a minimum return of 85% of the Investment Amount if trades were not profitable.
Between June 2019 and February 2020, CH Biovest entered into nine LOAs with EAM, investing a total of $5,480,246. In return, it received $7,799,730, which the parties treated as a “profit” of $2,319,484. This “profit” was the subject of the liquidators’ recovery claim. Critically, it was agreed that there were no actual nickel trading transactions carried out by EAM. Instead, any “profits” paid to investors were fictitious and were funded from the investments of other investors—an arrangement that functioned as a Ponzi scheme.
Regulatory and criminal developments followed. In March 2020, the Monetary Authority of Singapore (“MAS”) placed EAM on its Investor Alert List, noting misrepresentations to investors about licensing applications. The Envy group was subsequently restructured, with operations shifted to Envy Global Trading Pte Ltd (“EGT”) and a new receivables-based model introduced. However, the scheme quickly unravelled. In March 2021, the key person behind the Envy group, Mr Ng Yu Zhi, was charged with cheating and fraudulent trading, and the Envy companies applied for judicial management soon after.
Interim judicial managers (“IJMs”) were appointed on 27 April 2021 and issued a report concluding that the purported nickel trading business was non-existent. The IJMs identified potential recovery avenues against “Overwithdrawn Investors”, including CH Biovest. Winding up orders were made on 16 August 2021, and the second to fourth respondents were appointed as liquidators. The liquidators then commenced proceedings to recover only the “Overwithdrawn Sums” (the investor’s profit), not the entire amounts paid to CH Biovest.
What Were the Key Legal Issues?
The appeal raised both preliminary and substantive issues concerning the scope and applicability of statutory avoidance provisions in insolvency. First, CH Biovest argued that the avoidance provisions could not be invoked because the Overwithdrawn Sums were never EAM’s assets; rather, they were said to be held on trust for investors (including via a Quistclose trust or an institutional constructive trust). This issue went to whether the statutory clawback mechanisms could operate where the investor claimed a proprietary interest in the relevant funds.
Second, CH Biovest contended that the liquidators had chosen the wrong statutory basis for recovery. It suggested that the policy rationale of s 73B of the CLPA and s 224 of the IRDA did not align with the liquidators’ objective of achieving an even distribution among creditors, and that the proper route should have been avoidance provisions relating to unfair preference under the IRDA.
Substantively, the court had to determine whether the payments could be avoided under s 73B of the CLPA and/or s 224 of the IRDA. For s 73B, the focus included whether CH Biovest could rely on the statutory defence in s 73B(3) by showing that it provided good consideration and that EAM did not have the requisite intent to defraud creditors. For s 224, the court had to examine whether the payments were transactions at an undervalue, including whether CH Biovest provided consideration of adequate value and whether the statutory conditions relating to EAM’s inability to pay its debts were satisfied.
How Did the Court Analyse the Issues?
The Court of Appeal began by situating the case within the statutory framework for avoidance in insolvency. The liquidators’ claim was anchored in the avoidance provisions applicable at the time the payments were made. Because the Overwithdrawn Sums were paid partly before and partly after the legislative transition, the court treated s 73B of the CLPA as applicable to payments made before 30 July 2020, and s 224 of the IRDA as applicable thereafter. This approach ensured that the court applied the correct statutory regime to each payment.
On the preliminary trust-based argument, the investor’s position was that the funds were held on trust and therefore were not “assets” of the debtor available for avoidance. The Court of Appeal rejected this contention. The court’s reasoning reflected a practical insolvency perspective: where the scheme is fictitious and the “profits” are paid out of other investors’ money, the investor’s attempt to characterise the payments as trust property cannot defeat the statutory purpose of avoidance. The court treated the avoidance provisions as mechanisms to unwind transactions that deplete the insolvent estate, even where the recipient seeks to reframe the payment as something other than a debtor’s asset.
Relatedly, the court addressed CH Biovest’s argument that the liquidators had selected the wrong statutory route. The Court of Appeal did not accept that the liquidators were confined to unfair preference provisions. Instead, it emphasised that the statutory avoidance provisions are not mutually exclusive in the sense suggested by the appellant; rather, the correct provision depends on the nature of the transaction and the statutory elements. Where the statutory criteria for undervalue or fraudulent intent are met, the liquidators may invoke those provisions to recover the relevant sums.
Turning to the substantive elements, the court analysed s 73B of the CLPA. A key aspect was whether CH Biovest could establish the defence under s 73B(3), which in substance requires the recipient to show that it provided good consideration and that the statutory conditions for the defence are satisfied. The Court of Appeal held that the “consideration” for the Overwithdrawn Sums was not of adequate value. The court noted that CH Biovest had not provided additional value corresponding to the excess payments it received. Put differently, the “profit” portion was not supported by any real trading activity or genuine performance by EAM; it was paid out of funds contributed by other investors. That factual matrix undermined any attempt to treat the excess as consideration for which the statutory defence could operate.
For s 224 of the IRDA, the court examined whether the payments fell within the statutory concept of transactions at an undervalue. The analysis required the court to consider the structure of s 224(3)(a), including whether the payments fell within the “second limb” or “first limb” of that provision. The court’s reasoning focused on whether EAM was unable to pay its debts at the relevant time, and whether the recipient provided adequate value. The court concluded that the statutory requirements were satisfied. The absence of actual nickel trading, the Ponzi nature of the scheme, and the resulting depletion of the estate supported the conclusion that the payments were avoidable as undervalue transactions.
Finally, the Court of Appeal dealt with the investor’s unjust enrichment arguments and its contention that there was no total failure of consideration. While unjust enrichment was one of the grounds below, the appeal primarily turned on the statutory avoidance provisions. The court’s approach indicates that, in Ponzi-scheme contexts, the statutory clawback framework provides a direct route to recovery that can render broader restitutionary debates less central, particularly where the statutory elements are clearly met.
What Was the Outcome?
The Court of Appeal dismissed CH Biovest’s appeal. The effect was to uphold the High Court’s order requiring CH Biovest to repay the Overwithdrawn Sums, being the excess “profits” it had received from EAM under the LOAs. The liquidators’ recovery claim therefore succeeded, subject to the procedural and enforcement steps typical in liquidation.
Practically, the decision reinforces that investors who receive fictitious or Ponzi-funded returns may be required to disgorge those returns for the benefit of the general body of creditors, rather than retaining them as if they were legitimate profits supported by real underlying transactions.
Why Does This Case Matter?
This case is significant for insolvency practitioners because it clarifies how Singapore courts approach avoidance claims in Ponzi-scheme settings. The decision confirms that statutory avoidance provisions can be used to claw back “profits” paid to recipients even where the recipient argues that the payments were held on trust or were contractually owed. The court’s reasoning reflects a strong commitment to insolvency pari passu principles: where the debtor’s estate has been depleted by payments funded from other investors rather than genuine trading, the statutory mechanisms for recovery will be applied robustly.
From a doctrinal perspective, the case illustrates the interaction between proprietary claims (trust characterisation) and statutory avoidance. While trust arguments can be powerful in ordinary contexts, the court’s approach suggests that they will not automatically defeat avoidance where the underlying factual reality is that the debtor’s purported performance was non-existent and the “returns” were effectively redistribution of other investors’ funds. This has implications for how recipients should frame their defences and what evidential foundation is required to sustain trust-based arguments.
For lawyers advising liquidators, the decision supports the strategic use of s 73B of the CLPA and s 224 of the IRDA to recover excess payments. For investors and recipients, the case serves as a cautionary precedent: contractual entitlement to “appreciation” or “profits” will not necessarily protect a recipient from clawback where the statutory elements of undervalue or fraudulent intent are established and where the recipient cannot show adequate value for the excess sums received.
Legislation Referenced
- Conveyancing and Law of Property Act (Cap 61, 1994 Rev Ed) — s 73B
- Insolvency, Restructuring and Dissolution Act 2018 (Act 40 of 2018) — s 224
- Insolvency, Restructuring and Dissolution Act 2018 (Act 40 of 2018) — ss 438 and 439 (as referenced in the proceedings)
- Uniform Fraudulent Transfer Act (mentioned in the metadata)
Cases Cited
- [2008] SGHC 133
- [2024] SGCA 57
- [2024] SGHC 46
- [2025] SGCA 3
Source Documents
This article analyses [2025] SGCA 3 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.